Previous 10 | Next 10 |
2024-02-08 07:09:07 ET More on AstraZeneca AstraZeneca's Q4 Earnings: Recognizing The Underrated Gem's Growth Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition AstraZeneca beats t...
2024-02-06 22:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-02 12:43:50 ET Summary Regeneron returned to topline growth in 2023 and this has led to the company's valuation rising to my expected EV/revenue range. The company is making significant investments in the obesity space, focusing on preserving lean mass and reducing fat mas...
2024-02-02 07:13:00 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) Regeneron Pharmaceuticals Inc. (REGN) Am...
2024-02-01 14:03:04 ET Sanofi (SNY) Q4 2023 Earnings Call Transcript February 01, 2024, 08:30 AM ET Company Participants Eva Schaefer-Jansen - Head of IR Paul Hudson - CEO Houman Ashrafian - Global Head of R&D Brian Ford - EVP, Head of Specialty Care ...
2024-02-01 07:55:55 ET More on Sanofi: Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 Sanofi incurs loss in Q4 amid generic competition, currency woes Sanofi Non-GAAP EPS of Ȋ...
2024-02-01 07:03:54 ET More on Sanofi Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition Sanofi (SNY) JPMorgan 42nd Annual Healthcare Conference Call (Transcript) Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 Sanofi Non-GAAP EPS o...
IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...
2024-02-01 01:38:24 ET More on Sanofi Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 Sanofi to acquire Inhibrx rare disease asset in $2.2B deal Sanofi on track to snap its six-day ...
2024-01-31 11:34:01 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript) Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating) Teva Pharmaceutical Industries Limi...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...